SCANDONEST SPECIAL

This brand name is authorized in New Zealand, Romania, Singapore, United Kingdom, South Africa

Active ingredients

The drug SCANDONEST SPECIAL contains a combination of these active pharmaceutical ingredients (APIs):

1 Mepivacaine UNII 4VFX2L7EM5 - MEPIVACAINE HYDROCHLORIDE

Mepivacaine is an amide local anaesthetic. Mepivacaine has a rapid onset, a high potency of anaesthesia and a low toxicity. Read about Mepivacaine

2 Epinephrine UNII YKH834O4BH - EPINEPHRINE

Epinephrine is a direct acting sympathomimetic agent, which exerts effects on both α and β adrenoceptors. It has more pronounced effects on β than on α adrenoceptors, although α effects prevail at high doses. The effects of adrenaline include increased rate and force of cardiac contraction, cutaneous vasoconstriction and broncho-dilatation. Read about Epinephrine

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
N01BB53	Mepivacaine, combinations	N Nervous system → N01 Anesthetics → N01B Anesthetics, local → N01BB Amides
Discover more medicines within N01BB53

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: GB	Medicines & Healthcare Products Regulatory Agency	Identifier(s): 52447
Country: NZ	Medicines and Medical Devices Safety Authority	Identifier(s): 2919
Country: RO	Agenția Națională a Medicamentului și a Dispozitivelor Medicale	Identifier(s): W05646001
Country: SG	Health Sciences Authority	Identifier(s): 07074P
Country: ZA	Health Products Regulatory Authority	Identifier(s): Y/4/421